Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("FAIRBAIRN, L. J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1
Export

Selection :

  • and

Complete cDNA sequence of human foetal liver peroxisomal 3-oxoacyl-CoA thiolaseFAIRBAIRN, L. J; TANNER, M. J. A.Nucleic acids research. 1989, Vol 17, Num 9, issn 0305-1048, 3588 [1 p.]Article

Genotoxicity studies on the azo dye Direct Red 2 using the in vivo mouse bone marrow micronucleus testRAJAGURU, P; FAIRBAIRN, L. J; ASHBY, J et al.Mutation research. Genetic toxicology and environmental mutagenesis. 1999, Vol 444, Num 1, pp 175-180, issn 1383-5718Article

Long-term protection of hematopoiesis against the cytotoxic effects of multiple doses of nitrosourea by retrovirus-mediated expression of human O6-alkylguanine-DNA-alkyltransferaseJELINEK, J; FAIRBAIRN, L. J; DEXTER, T. M et al.Blood. 1996, Vol 87, Num 5, pp 1957-1961, issn 0006-4971Article

Erythroid development of the FDCP-Mix A4 multipotent cell line is governed by the relative concentrations of erythropoietin and interleukin 3HEYWORTH, C. M; ALAULDIN, M; CROSS, M. A et al.British journal of haematology. 1995, Vol 91, Num 1, pp 15-22, issn 0007-1048Article

Chemoprotective gene transfer II : Multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6-alkylguanine-DNA alkyltransferaseCHINNASAMY, N; RAFFERTY, J. A; HICKSON, I et al.Gene therapy (Basingstoke). 1998, Vol 5, Num 6, pp 842-847, issn 0969-7128Article

Protection of mammalian cells against chloroethylating agent toxicity by an O6-benzylguanine-resistant mutant of human O6-alkylguanine-DNA alkyltransferaseHICKSON, I; FAIRBAIRN, L. J; CHINNASAMY, N et al.Gene therapy (Basingstoke). 1996, Vol 3, Num 10, pp 868-877, issn 0969-7128Article

Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factorsFAIRBAIRN, L. J; COWLING, G. J; REIPERT, B. M et al.Cell (Cambridge). 1993, Vol 74, Num 5, pp 823-832, issn 0092-8674Article

MDR1 P-gp expression and activity in intact human placental tissue; Upregulation by retroviral transductionATKINSON, D. E; SIBLEY, C. P; FAIRBAIRN, L. J et al.Placenta (Eastbourne). 2006, Vol 27, Num 6-7, pp 707-714, issn 0143-4004, 8 p.Article

The effects of dose, route of administration, drug scheduling and MDR-1 gene transfer on the genotoxicity of etoposide in bone marrowTURNER, S. D; RAFFERTY, J. A; FAIRBAIRN, L. J et al.Leukemia. 2000, Vol 14, Num 10, pp 1796-1802, issn 0887-6924Article

Modulation of O6-alkylating agent induced clastogenicity by enhanced DNA repair capacity of bone marrow cellsCHINNASAMY, N; FAIRBAIRN, L. J; LAHER, J et al.Mutation research. Genetic toxicology and environmental mutagenesis. 1998, Vol 416, Num 1-2, pp 1-10, issn 1383-5718Article

Chemoprotection of normal tissues by transfer of drug resistance genesRAFFERTY, J. A; HICKSON, I; CHINNASAMY, N et al.Cancer metastasis reviews. 1996, Vol 15, Num 3, pp 365-383, issn 0167-7659Article

Retroviral transfer and expression of human MDR-1 in a murine haemopoietic stem cell line does not alter factor dependence, growth or differentiation characteristicsHEYWORTH, C. M; GAGEN, D; EDINGTON, K. G et al.Leukemia. 2002, Vol 16, Num 1, pp 106-111, issn 0887-6924Article

Assays to predict the genotoxicity of the chromosomal mutagen etoposide - focussing on the best assayTURNER, S. D; WIJNHOVEN, S. W. P; TINWELL, H et al.Mutation research. Genetic toxicology and environmental mutagenesis. 2001, Vol 493, Num 1-2, pp 139-147, issn 1383-5718Article

The expression of full length Gp91-Phox protein is associated with reduced amphotropic retroviral productionBELLANTUONO, I; LASHFORD, L. S; RAFFERTY, J. A et al.Haematologica (Roma). 2000, Vol 85, Num 5, pp 451-457, issn 0390-6078Article

Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells : implications for chemoprotective gene therapyCHINNASAMY, N; RAFFERTY, J. A; LASHFORD, L. S et al.Leukemia. 1999, Vol 13, Num 11, pp 1776-1783, issn 0887-6924Conference Paper

O6-Benzylguanine potentiates the in vivo toxicity and clastogenicity of temozolomide and BCNU in mouse bone marrowCHINNASAMY, N; RAFFERTY, J. A; HICKSON, I et al.Blood. 1997, Vol 89, Num 5, pp 1566-1573, issn 0006-4971Article

Expression of Epstein-Barr virus latent membrane protein influences self-renewal and differentiation in a multipotential murine haemopoietic stem cell lineFAIRBAIRN, L. J; STEWART, J. P; HAMPSON, I. N et al.Journal of general virology. 1993, Vol 74, pp 247-254, issn 0022-1317, 2Article

  • Page / 1